MRK.SN

Merck & Co., Inc.
SantiagoUSDEQUITY DELAYED
Last price
135.97
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
135.97
Day high
131.50
Day low
131.50
Volume
167
Market cap
P/E (TTM)
52W range
79.14 – 131.50

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
0.00% +1.2%
1M
0.00% -3.3%
3M
+11.72% +9.3%
6M
+11.54% -0.3%
YTD
+28.42% +16.5%
1Y
+66.16% +46.0%
3Y
+16.06% -58.9%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on MRK.SN open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $65.01B$64.17B$60.12B$59.28B +1.3%
Operating revenue $65.01B$64.17B$60.12B$59.28B +1.3%
Cost of revenue $16.38B$15.19B$16.13B$17.41B +7.8%
Gross profit $48.63B$48.98B$43.99B$41.87B -0.7%
Research & development $15.79B$17.94B$30.53B$13.55B -12.0%
Selling, general & admin $10.73B$10.82B$10.50B$10.04B -0.8%
Total operating expense $26.52B$28.75B$41.03B$23.59B -7.8%
Operating income $22.11B$20.22B$2.95B$18.28B +9.3%
Net interest income -$1.01B-$856.00M-$781.00M-$805.00M -18.5%
Pre-tax income $21.07B$19.94B$1.89B$16.44B +5.7%
Tax provision $2.80B$2.80B$1.51B$1.92B +0.0%
Net income $18.25B$17.12B$365.00M$14.52B +6.6%
Net income to common $18.25B$17.12B$365.00M$14.52B +6.6%
Basic EPS 7.386.770.145.73 +8.9%
Diluted EPS 7.286.740.145.71 +8.0%
EBIT $22.42B$21.21B$3.04B$17.41B +5.7%
EBITDA $28.26B$25.71B$6.91B$21.32B +9.9%
Basic shares 2.47B2.53B2.61B2.53B -2.1%
Diluted shares 2.51B2.54B2.61B2.54B -1.3%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
131.50
+3.40% from price
SMA 20
131.50
0.00% from price
SMA 50
127.45
+3.18% from price
SMA 100
122.58
+10.93% from price
SMA 200
113.71
+15.64% from price
EMA 12
131.44
+3.45% from price
EMA 26
130.51
+4.19% from price
EMA 50
128.00
+6.23% from price
RSI (14)
99.9
Overbought
MACD (12,26,9)
0.93
Hist -0.34
ATR (14)
0.00
Realised vol 30D
6.8%
Annualised
Bollinger upper
131.50
20, 2σ
Bollinger lower
131.50
20, 2σ
50 / 200 cross
Golden
127.45 vs 113.71
Trend bias
Above 200
+15.64%

Options chain

Account required
Expiry
Spot 135.97
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.00
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
6.8%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-2.2%
Peak to trough
Max drawdown 5Y
-40.5%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.